Johnson & Johnson to pay $6.3M as part of Infants' Tylenol class action settlement

Those who bought Infants' Tylenol may be entitled to a cash payment
Posted at 4:53 PM, Jan 10, 2020
and last updated 2020-01-10 16:57:26-05

If you purchased Infants' Tylenol in the last five-plus years, you may be entitled to a cash payment.

Tylenol's parent company Johnson & Johnson has agreed to pay $6.3 million as part of a class action settlement about the packaging and advertising of the said product. According to a press release from KCC Class Action Services LLC, the lawsuit claimed the Infants' Tylenol packaging deceived customers into believing that the medications were "unique/specifically formulated for infants." But instead, the lawsuit alleges the bottle contains liquid acetaminophen, which is the same concentration in Children's Tylenol, leading buyers into overpaying for Infants' Tylenol.

Johnson & Johnson denies the allegations of deception but ultimately reached a settlement to pay customers $2.15 for every one and two full ounce bottle of Infants' Tylenol purchased. Customers can receive up to $15.05, or seven bottles, in the cash payment.

The cash payment applies to customers who bought Infants' Tylenol from October 3, 2014 to January 6, 2020.

You can click here to access the claim form. The claim form must be submitted by April 13, 2020.

Below is the release from the class action settlement website:

RECOMMENDED: OPIOID TRIAL: Judge says Johnson & Johnson is liable in Okla. opioid crisis, company must pay $572M

Over the last year, Johnson & Johnson had been at the center of controversy over its role in the opioid crisis. In August of 2019, a judge in Oklahoma found Johnson & Johnson liable in the state's opioid drug crisis and ordered the company to pay $572 million to help abate the problem.